Axsome Therapeutics, Inc.
US ˙ NasdaqGM ˙ US05464T1043

SecurityAXSM / Axsome Therapeutics, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership603,465 shares
Latest Disclosed Value $ 101,997,654
D. E. Shaw & Co., Inc. ownership in AXSM / Axsome Therapeutics, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 603,465 shares of Axsome Therapeutics, Inc. (US:AXSM) valued at $101,997,654 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 549,113 shares of Axsome Therapeutics, Inc.. This represents a change in shares of 9.90% during the quarter. The current value of the position is $140,903,043 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (AXSM) in the form of stock options. The firm currently holds call options representing 3,700 of underlying shares valued at $625,374 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AXSM / Axsome Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM 05464T104 603,465 54,352 9.90 101,998 1.70 0.0613
2026-02-17 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 549,113 252,826 85.33 100,290 178.70 0.0550
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 296,287 95,523 47.58 35,984 71.70 0.0203
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 200,764 -346,901 -63.34 20,958 -67.19 0.0149
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM 05464T104 547,665 527,319 2,591.76 63,874 3,611.45 0.0569
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 20,346 17,446 601.59 1,721 561.92 0.0013
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM 05464T104 2,900 -3,434 -54.22 261 -48.92 0.0002
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 6,334 -1,435 -18.47 510 -17.77 0.0005
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM 05464T104 7,769 -1,415 -15.41 620 -15.21 0.0005
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 9,184 9,184 731 0.0006
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM 05464T104 0 -6,762 -100.00 0 -100.00
2022-08-15 2022-06-30 13F AXSOME THERAPEUTICS COM 05464T104 6,762 -148,630 -95.65 259 -95.97 0.0003
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM 05464T104 155,392 155,392 6,432 0.0060
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -13,939 -100.00 0 -100.00
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM 05464T104 13,939 -9,110 -39.52 459 -70.48 0.0004
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM 05464T104 23,049 -10,169 -30.61 1,555 -17.29 0.0013
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 33,218 -133,964 -80.13 1,880 -86.20 0.0018
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 167,182 -64,060 -27.70 13,620 -17.33 0.0122
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 231,242 -4,461 -1.89 16,476 -15.05 0.0169
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS COM 05464T104 235,703 -122,992 -34.29 19,394 -8.09 0.0231
2020-05-15 2020-03-31 13F AXSOME THERAPEUTICS COM 05464T104 358,695 275,232 329.77 21,102 144.60 0.0329
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS COM 05464T104 83,463 -36,488 -30.42 8,627 255.31 0.0099
2019-11-14 2019-09-30 13F AXSOME THERAPEUTICS COM 05464T104 119,951 85,195 245.12 2,428 171.28 0.0030
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS COM 05464T104 34,756 34,756 895 0.0011
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM Call 3,700 -57.47 625 -60.64 n/a n/a n/a
2026-02-17 2025-12-31 13F AXSOME THERAPEUTICS COM Call 8,700 31.82 1,589 98.25 n/a n/a n/a
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM Call 6,600 0.00 802 16.42 n/a n/a n/a
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM Call 6,600 0.00 689 -10.53 n/a n/a n/a
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM Call 6,600 -72.84 770 -62.60 n/a n/a n/a
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM Call 24,300 58.82 2,056 49.53 n/a n/a n/a
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM Call 15,300 50.00 1,375 67.48 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM Call 10,200 0.00 821 0.98 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM Call 10,200 -70.52 814 -70.47 n/a n/a n/a
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM Call 34,600 0.00 2,754 13.85 n/a n/a n/a
2023-11-14 2023-09-30 13F AXSOME THERAPEUTICS COM Call 34,600 0.00 2,418 -2.74 n/a n/a n/a
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM Call 34,600 13.07 2,486 31.74 n/a n/a n/a
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM Call 30,600 206.00 1,887 144.75 n/a n/a n/a
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM Call 10,000 771 n/a n/a n/a
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM Call 90,000 200.00 3,400 243.78 n/a n/a n/a
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM Call 30,000 0.00 989 -51.14 n/a n/a n/a
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM Call 30,000 0.00 2,024 19.13 n/a n/a n/a
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM Call 30,000 0.00 1,699 -30.48 n/a n/a n/a
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM Call 30,000 0.00 2,444 14.31 n/a n/a n/a
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM Call 30,000 0.00 2,138 -13.37 n/a n/a n/a
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS COM Call 30,000 -25.00 2,468 4.89 n/a n/a n/a
2020-05-15 2020-03-31 13F AXSOME THERAPEUTICS COM Call 40,000 300.00 2,353 127.56 n/a n/a n/a
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS COM Call 10,000 1,034 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM Put 31,500 0.00 2,665 -5.83 n/a n/a n/a
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM Put 31,500 0.00 2,831 11.64 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM Put 31,500 0.00 2,536 0.88 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM Put 31,500 2,514 n/a n/a n/a
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM Put 20,800 0.00 1,403 19.10 n/a n/a n/a
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM Put 20,800 0.00 1,178 -30.50 n/a n/a n/a
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM Put 20,800 0.00 1,695 14.37 n/a n/a n/a
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM Put 20,800 -49.02 1,482 -55.85 n/a n/a n/a
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS COM Put 40,800 96.15 3,357 174.26 n/a n/a n/a
2020-05-15 2020-03-31 13F AXSOME THERAPEUTICS COM Put 20,800 1,224 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.